Objective: The objective of this study was to evaluate the relationship between change in bone mineral density (BMD) and change in health related quality of life (HRQoL) over a 3-year period, in patients without incident of osteoporotic fracture.
BACKGROUND
The concept of health related quality of life (HRQoL) emerged as a means of measuring outcomes that are relevant to the patient [1] . Indeed, quality of life is a subjective multidimensional construct [2] . During the last few years, HRQoL has been assessed during interventional studies for patients with osteoporosis [3, 4] . It is often used as an outcome measure complementary to bone mineral density values and fracture incidence. In daily clinical practice, HRQoL tools help enhance patient-physician communication, monitoring response to therapy and detecting physical or psychological problems [5] [6] [7] . Several osteoporosis disease specific target instruments have been developed to evaluate HRQoL in patients who suffer from this chronic condition [8] [9] [10] [11] [12] [13] .
Osteoporosis is a chronic condition that increases bone fragility and causes an increased risk of fracture. Osteoporosis and its complications have a considerable impact on health related quality of life (HRQoL) [5, 9, 10, 14, 15] , partly due to pain [16] , restriction on activity [17] and alteration in mood [18] . Moreover, Hawker et al. showed that fractures give rise to bone deformation, dorsal fatigue and respiratory disorder [19] . Osteoporosis also robs older women of many of their social roles because it limits their physical and functional capability [20] . Depression may also be considered as an important psychological dimension associated with osteoporosis [21] [22] [23] . All these elements contribute to a deterioration of the HRQoL in patients with osteoporosis [15, 24] .
Some studies have assessed, cross-sectionally, the relationship between osteoporosis (mainly assessed by fractures) and HRQoL. They assessed HRQoL in patients with osteoporotic fractures or compared the HRQoL of postmenopausal women with and without osteoporotic fractures [6, [25] [26] [27] [28] [29] [30] [31] [32] . Some of these studies showed an impairment of HRQoL in patients with vertebral fractures [31, 32] but also the influence of number, type or severity of these on HRQoL [30, 31, 33] . For example, Oleksik et al., in a multicentric (7 countries) study involving 751 postmenopausal European women aged up to 80 years, showed that QUALEFFO scores increased significantly (impairment of HRQoL), progressively with an increase in vertebral fractures (p<0.001). The authors also showed a difference in HRQ L between patients with or without vertebral fractures (p<0.05). Adachi et al. evaluated the association of several types of fracture (hip, pelvis and wrist) with HRQoL in 3394 postmenopausal women aged over 50 years in the Canadian Multicenter Osteoporosis Study (CaMos) [31] . They showed an association between hip or pelvis osteoporotic fractures and impairment of HRQoL (measured using the health utility index Marx 2 and 3) but the relationship was unclear for upper body fractures. Dolan et al. showed a minimal impact of Colles' fractures on loss of HRQoL in 50 UK women (aged 52-91 years) using EQ-5D [34] . The author suggested that the loss of HRQoL was associated with Colles' fractures in about 2% of cases. In the OFELY study, the measurement of femoral neck BMD and HRQoL (with the self-administered osteoporosis targeted quality of life survey instrument -OPTQoL) was carried out in 756 French women (mean age of 59 years) with and without osteoporosis or osteoporotic fractures. The adaptation and fears domain scores were significantly worse among women with BMD in the osteoporotic range (T score -2.5 SD; p<0.05) in comparison with non osteoporotic patients.
To the best of our knowledge, very few studies have dealt with the relationship between bone mineral density (BMD) and quality of life over the long-term [35] . In a recent study, Dhillon showed that female patients with osteoporosis have a reduced HRQoL compared with the age-matched female, irrespective of a history of prior fracture [36] . Another study documented fears and psychological disability in women who had osteoporosis but were free of fractures [37] . A direct relationship between HRQoL and BMD could be hypothesized to explain these results. Moreover, treatment of low BMD in osteoporotic individuals seems be associated with improved HRQoL [38] .
The main purpose of this study was to assess 1) the relationship between HRQoL and BMD at baseline 2) the impact of changes in BMD on change in HRQoL score after 3 years.
METHOD
We used placebo data from two randomized, double blind, placebo-control trials assessing the effect and safety of a new anti-osteoporotic drug [39, 40] . The two studies were: the treatment of peripheral osteoporosis study (TROPOS) and spinal therapeutic osteoporosis intervention (SOTI). Women were eligible for the SOTI study if they were at least 50 years old, had been postmenopausal for at least five years, had had at least one prevalent vertebral fracture confirmed by spinal radiography and had a lumbar spine BMD of 0.840 g/cm 2 or less (corresponding to a T-score < -2.5). In the TROPOS study, the criteria for eligibility were a femoral neck BMD of 0.600 g/cm 2 or less (corresponding to a Tscore < -2.5), an age of 74 years or older, or an age of between 70 and 74 years with at least one additional risk factor for fracture. In these studies, women were ineligible if they had a severe disease or condition that might interfere with bone metabolism or if they used anti-osteoporotic treatment. For this particular study, we included patients who had not had new fractures during the 3-year follow-up period in order to see the real impact of BMD change on HRQoL. Patients received daily calcium supplements at lunchtime to maintain a daily calcium intake above 1500 mg and vitamin D supplements (400 to 800 IU, depending on their baseline serum concentration of 25-OHD). After a run-in period of 2 to 24 weeks, depending on the severity of the deficiency of calcium and vitamin D, the subjects in the placebo group received a placebo powder for 3 years (2 gr a day of powder, which they mixed with water). The protocol of this study was approved by the Ethics Committee of the University of Liege.
BMD was estimated at lumbar spine and at proximal femur by dual-energy X-ray absorptiometry at baseline and at six-month intervals (by Hologic). A quality control programme, including serial measurements of a spine phantom and daily quality controls, was conducted throughout the study [41] . This procedure was detailed in the main publications of both studies [39, 40] .
In this particular study, the specific QUAlity of LIfe questionnaire in OSTeoporosis (QUALIOST) [13] was used as a complement to the generic questionnaire medical outcome study Short Form 36 items (SF-36). The SF-36 measures quality of life using 36 items grouped into eight domains: physical functioning, role -physical, bodily pain, general health, vitality, social functioning, role -emotional and mental health. From these eight domains, two summary scores can be calculated: the physical and the mental component summary index [42, 43] . The score ranges from 100 (best) to 0 (worst).
The QUALIOST was designed for use as a complement to the SF-36 to measure established osteoporosis-specific quality of life. It includes 23 items and 8 multi functioning dimensions [13] . A total score (global score QUALIOST) can be calculated by summing the items. Scores vary between 0 (the worst score) and 100 (the best score representing perfect Quality of Life). This is except for back pain, climbing pain and general quality of life, for which scores vary between 1 and 5, with 1 corresponding to perfect HRQoL score for this item. This specific quality of life questionnaire was only used in a subgroup of the participants from SOTI.
Statistical analyses were performed using STATISTICA (version 7.1; StatSoft Inc). Normality of distribution was checked using the Shapiro-Wilk test. The correlation coefficient estimates were made using the Spearman correlation coefficient. The effect of BMD (for lumbar or femoral BMD) on HRQoL was assessed using multiple regression analysis adjusting for age, body mass index (BMI), number of prevalent fractures and, for change analysis, BMD at baseline, and HRQoL item value at baseline). For secondary analysis, patients were divided into groups during follow-up: patients with a BMD decrease higher than or equal to 3% and the others ( BMD >-3% or BMD -3%). This cut-off value is frequently used in clinical trials [44, 45] . The mean changes in HRQoL scores in the different groups were tested using the student T-test. P-values < 0.05 were regarded as statistically significant in all statistical tests. The minimal detectable change [46] (defined as one half of standard deviation at baseline) was considered as a clinically significant change for items with a score of between 0 and 100. 
RESULTS
This study included data from 1838 (1350 from TROPOS and 488 from SOTI) osteoporotic postmenopausal women. It should be pointed that only 63.5% (1168) of the 1838 subjects had both BMD and HRQoL values at baseline and after 3 years of follow-up. Moreover, only a fraction of the patients (432) received both the SF-36 and QUALIOST questionnaires.
Women included in this study were aged [mean (± S.D.)] 73.5 (6.2) years and more than 95% of the study population was aged 60 years or older. The mean BMD was 0.785 (0.145) g/cm at lumbar spine and 0.577 (0.071) g/cm at proximal femur. The number of fractures varied from 0 to 7 regarding peripheral fractures and from 0 to 13 regarding vertebral fractures. In our population, 697 (37.9%) of patients had no fractures. More characteristics of the study population are presented in Table 1 Table 2) . Women with a fracture had a lower HRQoL than women without a fracture ( Table 3 ).
Relationship at Baseline Between BMD and HRQoL
In univariate analysis, some weak but significant positive correlations appeared between lumbar BMD and different items of the HRQoL at baseline ( 
Relationship Between Change in HRQoL and Change in BMD
After 3 years of follow-up, we had BMD data and at least one HRQoL item value for 1168 subjects. In our population, the global score QUALIOST increased by 14 After 3 years of follow-up, in unadjusted analysis, we found no significant correlation between change in lumbar BMD and change in different items of HRQoL (p between 0.25 and 0.99) except in the case of change in the standardized physical component of the SF-36 (p=0.029) and general health perception (p=0.042). After adjusting for age, BMI, number of prevalent vertebral and peripheral fractures, BMD at baseline and value of HRQoL at baseline, multiple regressions did not show a significant relationship between change in the main HRQoL items and lumbar BMD change (p between 0.465 and 0.884). We also compared HRQoL scores between patients with a decrease in lumbar BMD of 3% or more and other patients. No statistically significant difference appeared between the groups ( Table 6) .
In univariate analysis, no significant relationship appeared between femoral BMD and HRQoL except for one negative significant correlation with change in the physical item of the QUALIOST (p=0.019). When considering change in femoral BMD and change in HRQoL items, multiple regressions (after adjusting for age, BMI, number of prevalent vertebral and peripheral fracture, BMD at baseline and value of HRQoL at baseline) showed a significant relationship between change in femoral BMD and change in the standardized physical component of the SF-36 (p=0.031; r =0.214). No significant difference regarding HRQoL change was observed when we compared patients with a decrease in femoral BMD of 3% or more to the other patients ( Table 7) .
DISCUSSION
This study is, to the best of our knowledge, one of the first assessing, prospectively, the associations between BMD (measured at two different sites) and HRQoL in women without incident of fracture.
Very few studies have dealt with the influence of BMD alone on HRQoL [35, 47] . Some studies suggest that osteoporosis decreases HRQoL [35] . They also observed better HRQoL scores in normal subjects compared to osteopenic or osteoporotic patients (p<0.05) for domains exploring general health perception and mental function. Recently, in a prospective trial of 325 women (96%) and men aged [mean (± S.D.)] 60 (±11) years, Dhillon et al. demonstrated a decreasing HRQoL (measured with EQ-5D, a generic self-report questionnaire) in osteoporotic women compared to the non osteoporotic population, irrespective of a history of prior fracture [36] . They showed an association between hip or pelvis osteoporotic fractures and impairment of HRQoL (measured using the health utility index Marx 2 and 3) but the relationship was unclear for upper body fractures. Dolan et al. showed a minimal impact of Colles' fractures on loss of HRQoL in 50 UK women (aged 52-91 years) using EQ-5D [47] . Their study, involving 1129 postmenopausal patients [mean age 67.2 (11.9) years] showed that several modifiable factors (for example: smoking, medication, diabetes…) influenced HRQoL in patients with vertebral fractures. However, they did not assess the influence of BMD in their study [47] . In their study, Romagnoli et al. showed that both vertebral fracture and a reduced BMD impairs some aspects of HRQoL perception (measured using QUALEFFO) in 361 asymptomatic ambulant women [48] [49] [50] but not consistently reported [35] to be associated with low BMD of the spine. However, it has not been clearly proven whether this potential association might be related to psychiatric disorder alone or to the hormonal or nutritional disorders associated with depression. Moreover, early in the disease process, women report high levels of anxiety caused in large part, by their very real fear of future fractures [51, 52] . Generally, a score of 35 for the mental component of the SF-36 is considered as indicating mental distress [53] . Our results do not show the relationship between change in BMD and change in mental health items after 3 years of follow-up.
Change in lumbar BMD was positively correlated with change in the standardized physical component of the SF-36 and change in general health perception in our population. Osteoporosis sometimes causes a restriction on social and leisure activities and may severely affect a woman's mood [5, 18] .
In the study of Romagnoli et al., administration of the QUALEFFO questionnaire to women suggested that low femoral neck BMD was associated with poorer physical functioning [35] . Our results confirm this observation. Multiple regression definitely showed a significant relationship between change in femoral BMD and change in the standardized physical component of the SF-36 (p=0.031; r =0.214).
One of the strengths of this study is that it involves a large population, and this reinforces the reliability of our results. Moreover, the women in the study had no disease or condition that could interfere with bone metabolism at baseline and they did not use anti-osteoporotic treatment except for calcium and vitamin D supplements. Analysis was based on validated tools (DXA, SF-36, and QUALIOST), which were collected during a large prospective placebo-controlled trial. These results were robust to adjustment for known prior fracture history.
Multiple regression analysis was performed with adjustment for age, BMI, number of prevalent vertebral and peripheral fractures, BMD at baseline and value of HRQoL at baseline. However, we did not have data concerning different factors that could influence HRQoL values; smoking status, other disease conditions or exercise level. We only knew that the patients did not have a pathology or other condition that could interfere with bone metabolism and that they were not using anti-osteoporotic treatment [39, 40] .
We did not find any statistically significant differences concerning the HRQoL score between patients with a decrease in BMD of 3% or more and the others for the two BMD sites measured (except for one borderline significant difference). However, it was shown that, with age, the presence or worsening of degenerative conditions of the spine, such as osteophytes and endplate sclerosis, could contribute to a variation in lumbar spine BMD measurement [54] .
The patients in this study received calcium and vitamin D supplements, which may have a positive effect on bone health and could possibly have modified our result [55] [56] [57] .
It is also possible that a placebo effect affected our results [58, 59] . For example in their study involving 1896 women and men aged 35 to 60 year, Bouchet et al. showed a significant effect of placebo on improving the physical, mental and pain dimension of the SF-36 (p=0.02 to 0.04) compared to a control group [59] . An interesting study [60] , published some years ago suggests a positive effect of participation in a clinical trial on HRQoL. Perhaps our second HRQoL score was affected because of participation in the trial.
The choice of tools used in this study could also have affected our results. The generic quality of life questionnaire chosen for our study was the Short Form 36 items (SF-36). This questionnaire has been widely adopted [25, 28, 61] and has been well validated for use in many countries and for many disease processes, including osteoporosis [62] [63] [64] [65] [66] . One of the strongest attributes of the SF-36 is its consistently high levels of reliability (test-retest and internal consistency) and validity (content, concurrent, criterion, construct and predictive) [63, 67] . This questionnaire is obviously not specific to osteoporosis. In our population, we observed that a minority of patients seemed to demonstrate a clinically significant change for items after 3 years of follow-up.
The QUALIOST was developed as a specific module of a generic questionnaire (SF-36), in order to focus on domains related to osteoporosis that were not already covered by the generic instrument [13] . The QUALIOST has demonstrated good reliability and good construct and criterion validity [52] . However, this questionnaire has not been widely used in epidemiological studies. The specific items of the QUAL-IOST were generated simultaneously in French and in English and the questionnaire was subject to a psychometric evaluation in 140 osteopenic British and French women [52] . Moreover, low responsiveness is described in the literature for the physical and emotional components and for the total score of the QUALIOST (effect size 0.15-0.17) regarding vertebral fractures [13] . Moreover, when we compare HRQoL scores for patients with or without incident of fracture at baseline, QUALIOST showed results quite the opposite of those of the SF-36. The use of another specific HRQoL questionnaire from those that have been developed for use in patients with osteoporosis [9, 11, 12, 68, 69] , including the Ecos-16 [68] , the Osteoporosis Quality of Life Questionnaire [5, 69] , the mini-Osteoporosis Quality of Life Questionnaire [5] and the Questionnaire of the European Foundation for Osteoporosis [9] , could perhaps have changed our results. After 3 years of follow-up, few patients seemed to obtain clinically significant changes with QUAL-IOST (between 3.9 and 29.9% of patients, depending on the items).
Despite the high number of patient (1838) included in this study, it should be acknowledged that only 63.5% (1168) of them had both BMD and HRQoL values at baseline and after 3 years of follow-up. Moreover, only a fraction of the patients (432) received both the SF-36 and QUALI-OST questionnaires. As a consequence, the statistical power of this study was sometimes low for some of the analyses (generally <30%). However, Dennison et al. pointed out the same problem in the Hertfordshire cohort study [70] .
CONCLUSION
In conclusion, our results suggest that BMD could partly affect HRQoL, but the exact mechanisms of action are unknown. However, these results were not enough to indicate a real clinically interesting relationship between HRQoL and BMD. Other studies would need to be performed in order to verify and explain these results.
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